Skip to Main Content

Paper Details

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.
Science
283
2014
L1, L1 elements, L1 promoter, L1s, Long interspersed nuclear element-1, Long interspersed nuclear element-1 (L1) retrotransposons, RNA intermediates, cancer, cancer genomes, exons, genes, genome, germ, heterochromatic regions, human, human genome, mobile repetitive elements, nonrepetitive DNA, nonrepetitive sequences, patients, regulatory elements, tumor, tumors
Author NameAffiliation
Inigo MartincorenaWellcome Trust Sanger Institute
Susanna L CookeWellcome Trust Sanger Institute
Gunes GundemWellcome Trust Sanger Institute
Jorge ZamoraWellcome Trust Sanger Institute
Keiran RaineWellcome Trust Sanger Institute
Andrew MenziesWellcome Trust Sanger Institute
Moritz GerstungWellcome Trust Sanger Institute
Patrick S TarpeyWellcome Trust Sanger Institute
Peter Van LooWellcome Trust Sanger Institute
Peter Van Loo
Manasa RamakrishnaWellcome Trust Sanger Institute
David C WedgeWellcome Trust Sanger Institute
Jon TeagueWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Serena Nik-ZainalWellcome Trust Sanger Institute
Serena Nik-ZainalCambridge University Hospitals National Health Service (NHS) Foundation Trust
Ludmil B AlexandrovWellcome Trust Sanger Institute
Ludmil B AlexandrovWellcome Trust Sanger Institute
Laura MudieWellcome Trust Sanger Institute
Claire HardyWellcome Trust Sanger Institute
Stuart McLarenWellcome Trust Sanger Institute
Sarah O'MearaWellcome Trust Sanger Institute
Elizabeth AndersonWellcome Trust Sanger Institute
Mark MaddisonWellcome Trust Sanger Institute
Stephen GambleWellcome Trust Sanger Institute
Christopher S FosterUniversity of Liverpool and HCA Pathology Laboratories
Anne Y WarrenCambridge University Hospitals National Health Service (NHS) Foundation Trust
Hayley C WhitakerCancer Research UK (CRUK) Cambridge Institute, University of Cambridge
Daniel S BrewerInstitute of Cancer Research
Daniel S BrewerUniversity of East Anglia
Rosalind A EelesInstitute of Cancer Research
Colin S CooperInstitute of Cancer Research
Colin S CooperUniversity of East Anglia
David E NealCancer Research UK (CRUK) Cambridge Institute, University of Cambridge
Andy G LynchCancer Research UK (CRUK) Cambridge Institute, University of Cambridge
Tapio VisakorpiInstitute of Biosciences and Medical Technology-BioMediTech, University of Tampere and Tampere University Hospital
William B IsaacsJohns Hopkins University
Laura J Van't VeerNetherlands Cancer Institute
Carlos CaldasCancer Research UK (CRUK) Cambridge Institute, University of Cambridge
Christos SotiriouInstitut Jules Bordet, Universite Libre de Bruxelles
Samuel Aparicio
Sunil R LakhaniUniversity of Queensland
Sunil R LakhaniUQ Centre for Clinical Research, University of Queensland
Sunil R LakhaniRoyal Brisbane and Women's Hospital
Sunil R LakhaniUniversity of Queensland
Sunil R LakhaniRoyal Brisbane and Women's Hospital
Sunil R LakhaniUQ Centre for Clinical Research, University of Queensland
Gilles ThomasUniversite Lyon 1, Institut National du Cancer (INCa)-Synergie
Ola MyklebostInstitute for Cancer Research, Oslo University Hospital
Paul N SpanRadboud University Medical Center
  • 1 - 50

Datasets